We are live on ! Find out more
AC

Armistice Capital Portfolio holdings

AUM $5.62B
1-Year Est. Return 36.06%
This Fund
S&P 500
This Quarter Est. Return
+7.98%
1 Year Est. Return
+36.06%
3 Year Est. Return
+44.14%
5 Year Est. Return
+38.37%
10 Year Est. Return
+188.88%
AUM
$6.25B
AUM Growth
-$1.7B
Cap. Flow
-$2.08B
Cap. Flow %
-33.31%
Top 10 Hldgs %
54.24%
Holding
331
New
77
Increased
88
Reduced
65
Closed
73

Top Buys

Rank Stock Value
1
FIVN icon
FIVE9
FIVN
+$41.6M
2
NARI
Inari Medical, Inc. Common Stock
NARI
+$39M
3
DPZ icon
Domino's
DPZ
+$33.2M
4
INCY icon
Incyte
INCY
+$27.6M
5
HUM icon
Humana
HUM
+$26.5M

Top Sells

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$109M
2
EXAS
Exact Sciences
EXAS
+$59.2M
3
SNY icon
Sanofi
SNY
+$49.7M
4
KDP icon
Keurig Dr Pepper
KDP
+$49.6M
5
GSK icon
GSK
GSK
+$39.9M

Sector Composition

Rank Sector Weight
1 Healthcare 41.55%
2 Consumer Discretionary 7.13%
3 Consumer Staples 5.35%
4 Technology 5.24%
5 Communication Services 0.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BCTXW
226
DELISTED
BriaCell Therapeutics Corp Warrant
BCTXW
$154K ﹤0.01%
375,000
– –
BGMS
227
Bio Green Med Solution Inc
BGMS
$5.3M
$144K ﹤0.01%
604
+46
+8% +$14.8K
TOVX icon
228
Theriva Biologics
TOVX
$10.3M
$138K ﹤0.01%
+100,000
New +$488K
NXTC icon
229
NextCure
NXTC
$21.8M
$137K ﹤0.01%
8,333
+5,333
+178% +$98.1K
MYSZ icon
230
My Size
MYSZ
$1.88M
$131K ﹤0.01%
78,000
+52,000
+200% +$116K
IDAI icon
231
T Stamp
IDAI
$18.2M
$130K ﹤0.01%
+39,328
New +$213K
FGIWW
232
FGI Industries Warrant
FGIWW
$225K
$121K ﹤0.01%
933,333
– –
APCX
233
DELISTED
AppTech Payments
APCX
$112K ﹤0.01%
+188,000
New +$168K
EDBL
234
Edible Garden
EDBL
$1.23M
$98.4K ﹤0.01%
+33
New +$412K
STAF
235
DELISTED
Staffing 360 Solutions, Inc. Common Stock (DE)
STAF
$93.2K ﹤0.01%
68,000
+51,100
+302% +$96.9K
AVGR
236
DELISTED
Avinger, Inc. Common Stock
AVGR
$77K ﹤0.01%
81,000
+37,253
+85% +$48.6K
LCFYW icon
237
Locafy Ltd Warrant
LCFYW
$74.4K ﹤0.01%
12,121
– –
SQFTW icon
238
Presidio Property Trust Inc Series A Warrants
SQFTW
$198K
$70K ﹤0.01%
2,000,000
– –
ONFOW icon
239
Onfolio Holdings Warrant
ONFOW
$32.6K
$68K ﹤0.01%
400,000
– –
CYTO
240
DELISTED
Altamira Therapeutics Ltd
CYTO
$61.9K ﹤0.01%
+101,444
New +$101K
SKYAW
241
SkyAI Inc
SKYAW
$263K
$59.7K ﹤0.01%
1,176,000
– –
OLOX
242
Olenox Industries
OLOX
$4.77M
$58.3K ﹤0.01%
95
-38
-29% -$37.1K
MOBBW
243
Mobilicom Ltd Warrants
MOBBW
$2.83B
$41.3K ﹤0.01%
242,100
– –
GXAI
244
Gaxos.ai
GXAI
$9.38M
$35K ﹤0.01%
22,000
-81,000
-79% -$189K
NXLIW
245
DELISTED
Nexalin Technology Inc Warrant
NXLIW
$33.3K ﹤0.01%
325,000
– –
SVREW
246
SaverOne 2014 Ltd Warrant
SVREW
$19.4K ﹤0.01%
242,100
– –
SWAGW icon
247
Stran & Company Warrant
SWAGW
$91.1K
$14.3K ﹤0.01%
545,000
– –
VTAK icon
248
Catheter Precision
VTAK
$964K
$14.2K ﹤0.01%
1,895
-618
-25% -$19.9K
SBEV.WS
249
DELISTED
Splash Beverage Group, Inc. Warrants to purchase 1/40th of a share of Common Stock at an exercise price of $184.00
SBEV.WS
$9.13K ﹤0.01%
904,000
– –
RVSNW icon
250
Rail Vision Ltd Warrant
RVSNW
$967K
$6.18K ﹤0.01%
136,187
– –
8 9
10
11 12

Similar funds

CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return
RMDI
R.M. Davis Inc Portland, Maine $5.63B AUM 21.26% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
EW
Evoke Wealth Los Angeles, California $5.57B AUM 23.85% 1-Year Est. Return
O
Ossiam Paris, France $5.69B AUM 30.95% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
ACM
Altimeter Capital Management Boston, Massachusetts $5.7B AUM 36.74% 1-Year Est. Return
PI
PGGM Investments Zeist, Netherlands $5.7B AUM 17.05% 1-Year Est. Return

Armistice Capital's Q3 2024 Portfolio in Review

As of Q3 2024, Armistice Capital held 331 positions worth $6.25B, down 21% from $7.95B the previous quarter. Its ten largest holdings account for 54% of the portfolio.

Armistice Capital withdrew a net $2.08B in Q3 2024, closing 73 positions and reducing 65 holdings. Its most notable exit was Exact Sciences, an estimated $59.2M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 33% a quarter earlier, followed by Consumer Discretionary and Consumer Staples.

Against the trend, Armistice Capital opened a new position in Paramount Global Class B worth $21.2M.

  • Armistice Capital's largest Q3 2024 buy was Paramount Global Class B: 2,000,000 shares worth $21.2M.
  • Armistice Capital added most to FIVE9 in Q3 2024, an estimated $41.6M increase.
  • Armistice Capital's biggest Q3 2024 reduction was Neurocrine Biosciences, cutting an estimated $109M.
  • Armistice Capital fully exited Exact Sciences in Q3 2024, selling an estimated $59.2M.
  • Armistice Capital's ten largest holdings make up 54% of its $6.25B portfolio in Q3 2024.
  • Armistice Capital opened 77 new positions and closed 73 in Q3 2024.
  • Armistice Capital's portfolio value fell 21% quarter-over-quarter to $6.25B.

Based on Armistice Capital's 13F filing for Q3 2024, filed 14 Nov 2024.